º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Manufacturing

Smith & Nephew to invest £80m in new East Yorkshire site - moving out of Hull after century stay

Eight mile move west will enable the business to stay at the cutting edge of wound management

Smith & Nephew's proposed new site at Melton West Business Park.(Image: Smith & Nephew)

Medical giant Smith & Nephew is to relocate its Hull operations down the A63 to Melton in an £80 million investment.

The global giant, founded in the city more than 150 years ago, is to build a new “world-class” research and development and manufacturing facility for its advanced wound management business at the 200-acre business park.

Simon Fraser, president of advanced wound management at Smith & Nephew, said: “This major investment demonstrates our commitment to the º£½ÇÊÓÆµ and to building our leadership in advanced wound management. Our vision is for a world-class working environment that encourages innovation and collaboration to deliver next-generation products that improve the standard of care for the NHS and customers around the world.

Read more: Buyer of Novartis Grimsby outlines what could be next for 'world-class' pharmaceutical complex

“Smith & Nephew was founded in Hull in 1856 and we are proud to make this major investment in the region for future generations."

Subject to planning approval, the new facility will be at Melton West business park, eight miles from the prominent site by Daltry Street flyover,where around 800 are employed.

It will replace the location, occupied for more than 100 years.

The team said the new facility will benefit from advanced laboratories better able to support the development of new technologies to “satisfy unmet clinical needs”, adding it will “ensure that the º£½ÇÊÓÆµ remains one of the world's leading wound care R&D locations”.